We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Fred Hutchinson Cancer Research Center and GenoLogics to Collaborate on Developing a Biomedical Informatics Solution
News

Fred Hutchinson Cancer Research Center and GenoLogics to Collaborate on Developing a Biomedical Informatics Solution

Fred Hutchinson Cancer Research Center and GenoLogics to Collaborate on Developing a Biomedical Informatics Solution
News

Fred Hutchinson Cancer Research Center and GenoLogics to Collaborate on Developing a Biomedical Informatics Solution

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Fred Hutchinson Cancer Research Center and GenoLogics to Collaborate on Developing a Biomedical Informatics Solution"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

GenoLogics has announced that the Fred Hutchinson Cancer Research Center has selected GenoLogics to collaborate with the company develop an integrated biorepository and biomedical informatics software solution for the Center’s Translational and Outcomes Research group.

The GenoLogics software is being provided to Fred Hutchinson Cancer Research Center by the Canary Foundation, a nonprofit, tax exempt public charity committed to the development of early-detection tests for solid-tumor cancers.

Fred Hutchinson Cancer Research Center focuses on discovering new ways to detect cancers earlier, developing effective treatments with fewer side effects and learning how to prevent cancers from growing in the first place. To connect the clinical and discovery research processes, the Center pursues translational research under its Translational and Outcomes Research group.

“To assist with realizing our vision for translational research, we needed a suite of informatics solutions that enables us to work seamlessly with clinical and laboratory researchers, as well as patients and healthy individuals,” says Dr. Nicole Urban, Head of the Translational and Outcomes Research group.

“Given the importance of collecting the clinical information to achieve this vision, we decided to work with a commercial vendor to provide our biomedical informatics solution. GenoLogics not only has a collaborative approach to developing a solution for us, but our visions around translational research are highly synergistic.”

GenoLogics launched its Biomedical Informatics software solution to address the needs of translational research initiatives to track observational studies, collect patient data at remote sites, provide biospecimen and clinical annotations management and facilitate researchers querying on clinical information and requesting samples.

The suite is comprised of five integrated products: BioVault for biospecimen management; BioChronicle for clinical annotations management; BioQuest to enable Web access; BioSphere for study management; and BioSource to enable electronic patient questionnaires.

“We are very excited to be working with Fred Hutchinson Cancer Research Center as our lead customer to develop our suite of biomedical informatics products,” says Michael Ball, CEO of GenoLogics. “We are developing our new Biomedical Informatics solution to complement our market-leading Research Informatics product line, which together enable research centers to pursue their translational research vision.”

Advertisement